These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Low-molecular-weight heparin compared with aspirin for the treatment of acute ischaemic stroke in Asian patients with large artery occlusive disease: a randomised study. Wong KS, Chen C, Ng PW, Tsoi TH, Li HL, Fong WC, Yeung J, Wong CK, Yip KK, Gao H, Wong HB, FISS-tris Study Investigators. Lancet Neurol; 2007 May; 6(5):407-13. PubMed ID: 17434095 [Abstract] [Full Text] [Related]
5. Low-molecular-weight heparin is more effective than aspirin in preventing early neurologic deterioration and improving six-month outcome. Yi X, Lin J, Wang C, Zhang B, Chi W. J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1537-44. PubMed ID: 24656240 [Abstract] [Full Text] [Related]
7. Frequency of microemboli signal in stroke patients treated with low molecular weight heparin or aspirin. Hao Q, Chang HM, Wong MC, Wong KS, Chen C. J Neuroimaging; 2010 Apr; 20(2):118-21. PubMed ID: 19141068 [Abstract] [Full Text] [Related]
11. Effect of combined aspirin and extended-release dipyridamole versus clopidogrel on functional outcome and recurrence in acute, mild ischemic stroke: PRoFESS subgroup analysis. Bath PM, Cotton D, Martin RH, Palesch Y, Yusuf S, Sacco R, Diener HC, Estol C, Roberts R, PRoFESS Study Group. Stroke; 2010 Apr; 41(4):732-8. PubMed ID: 20181679 [Abstract] [Full Text] [Related]
17. Rationale and design of the PreventIon of CArdiovascular events in iSchemic Stroke patients with high risk of cerebral hemOrrhage (PICASSO) study: A randomized controlled trial. Hong KS, Kim BJ, Lee JY, Kwon SU, PICASSO Investigators. Int J Stroke; 2015 Oct; 10(7):1153-8. PubMed ID: 26044566 [Abstract] [Full Text] [Related]